| abstract |
The present invention relates to (rac)-N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-1H- pyrazole-3-carboxamide • X H2O, with X between 0.7 and 0.3. Especially preferred is (rac)-N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-1H- pyrazole-3-carboxamide • monohydrate. Methods for their preparation, and their use as modulators of the cannabinoid receptor are also disclosed. |